trending Market Intelligence /marketintelligence/en/news-insights/trending/ywztxOrkTQM-dduMas1eEg2 content esgSubNav
In This List

Global Blood Therapeutics adds director

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Global Blood Therapeutics adds director

Global Blood Therapeutics Inc. appointed Dawn Svoronos to its board.

Svoronos serves on the boards of Endocyte Inc., PTC Therapeutics Inc., Theratechnologies Inc. and Xenon Pharmaceuticals Inc. Previously, she acted as director and interim chief commercial officer of Medivation Inc. In addition, she was president of Merck Canada Inc.

South San Francisco, Calif.-based Global Blood Therapeutics is a clinical-stage biopharmaceutical company developing two therapies for the potential treatment of sickle cell disease.